Flash Forward is a show about possible (and not so possible) future scenarios. What would the warranty on a sex robot look like? How would diplomacy work if we couldn’t lie? Could there ever be a fecal transplant black market? (Complicated, it wouldn’t, and yes, respectively, in case you’re curious.) Hosted and produced by award winning science journalist Rose Eveleth, each episode combines audio drama and journalism to go deep on potential tomorrows, and uncovers what those futures might re ...
…
continue reading
Player FM - Internet Radio Done Right
Checked 1d ago
Vor drei Jahren hinzugefügt
Inhalt bereitgestellt von touchpodcast. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von touchpodcast oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Player FM - Podcast-App
Gehen Sie mit der App Player FM offline!
Gehen Sie mit der App Player FM offline!
touchPODCAST
Alle als (un)gespielt markieren ...
Manage series 3389426
Inhalt bereitgestellt von touchpodcast. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von touchpodcast oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
…
continue reading
498 Episoden
Alle als (un)gespielt markieren ...
Manage series 3389426
Inhalt bereitgestellt von touchpodcast. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von touchpodcast oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
…
continue reading
498 Episoden
Alle Folgen
×t
touchPODCAST

1 Navigating the treatment of RRMM with BCMA-directed therapies: Updates from COMy, ASCO and EHA 2025 1:09:32
1:09:32
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked1:09:32
touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2025 congresses. Prof. Moreau is then joined by fellow experts Dr Paola Neri and Prof. Hermann Einsele to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Moreau Expert panel discussions with Prof. Moreau, Dr Neri and Prof. Einsele on the themes below Clinical themes Approved BCMA-directed therapeutic approaches Practical application of BCMA-directed therapies Future of treating RRMM: Emerging BCMA-directed therapies and combinations The internationally renowned multiple myeloma expert faculty Prof. Philippe Moreau: Nantes, France Prof. Hermann Einsele: Würzburg, Germany Dr Paola Neri: Calgary, AB, Canada This touchPODCAST is for HCPs outside of the USA. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: www. touchHAEMATOLOGY.com and www. touchONCOLOGY.co m…
touchEXPERT FOCUS for touchDERMATOLOGY Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with a focus on timely referral and effective risk stratification. She also explores current and emerging treatment options and practical strategies to support families throughout a patient’s care journey. The expert: Prof. Ilona Frieden, University of California, San Francisco, CA, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Pierre Fabre Pharmaceuticals, Inc. This activity is jointly provided by USF Health and touchIME in collaboration with our education partner, Pediatric Dermatology Research Alliance (PeDRA). For further information visit our website: https://touchdermaime.org/…
t
touchPODCAST

1 Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist 35:34
touchIN CONVERSATION for touchONCOLOGY Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities. The experts Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Gilead Sciences, Inc. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchoncologyime.org/adcs-in-the-treatment-of-mbc/…
t
touchPODCAST

1 Multidisciplinary management of TNBC Integrating immunotherapies for early and metastatic disease 36:07
touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits. The experts: Prof. Sherko Kümmel – Kliniken Essen-Mitte, Essen, Germany Prof. Rebecca Dent – National Cancer Center Singapore, Singapore Prof. Peter Schmid – Barts Cancer Institute, London, UK This touchPODCAST is for healthcare professionals outside of the UK. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/management-of-tnbc-with-immunotherapy/…
t
touchPODCAST

touchEXPERT FOCUS for touchRESPIRATORY Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation. The expert Prof. Jonathan Spicer, McGill University, Montreal, Canada This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchrespiratoryime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/…
t
touchPODCAST

touchEXPERT FOCUS for touchONCOLOGY Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation. The expert Prof. Jonathan Spicer, McGill University, Montreal, Canada This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchoncologyime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/…
t
touchPODCAST

1 Towards personalized care for people living with HIV: Supporting open dialogue and informed treatment choices 34:02
NEW touchCASES for touchINFECTIOUS DISEASES Listen to Prof. José Arribas, a leading HIV expert, and Ms Harriet Langanke, a journalist and HIV activist, discuss personalized care strategies for people living with HIV, focusing on three key concerns: weight gain, pill fatigue and treatment initiation. The experts: Prof. José Arribas, University Hospital La Paz, Madrid, Spain, Ms Harriet Langanke, GSSG, Cologne, Germany This touchPODCAST is for HCPs outside of the UK This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchinfectiousdiseases.com…
touchFOCUS for touchONCOLOGY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc . This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchoncology.com…
touchFOCUS for touchRESPIRATORY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc . This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchrespiratory.com…
touchEXPERT FOCUS touchOPHTHALMOLOGY Listen to Dr Laura Periman share expert insights on dry eye disease. In this episode, she explores the pathophysiological mechanisms behind the condition, highlights key diagnostic tools, reviews current treatment options—including exciting advances in neuromodulation therapies—and discusses emerging targeted approaches shaping clinical management today. The expert Dr Laura Periman, Periman Eye Institute, Seattle, WA, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from A lcon Vision, LLC. The activity is jointly provided by USF Health and touchIME. For further information, visit our website: https://touchophthalmologyime.org/advances-in-dry-eye-disease/…
t
touchPODCAST

1 Recent advances in the care of patients with geographic atrophy: Bringing new and emerging therapies into focus 35:33
touchIN CONVERSATION for touchOPHTHALMOLOGY Listen to two experts in geographic atrophy (GA) discuss recent advances in the care of patients. They explore the importance of early identification of GA and how this can be achieved, examine the potential impact of new and emerging therapies for GA, and highlight key practical considerations for monitoring treatment outcomes and evaluating effectiveness of therapy in clinical practice. The experts Prof. Giuseppe Querques, IRCCS Hospital San Raffaele, Milan, Italy Dr Arshad M. Khanani, Sierra Eye Associates, Reno, NV, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Astellas Pharma Inc. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchophthalmologyime.org/…
touchEXPERT FOCUS for touchNEUROLOGY Join Prof. Montalban as he shares expert insights into the pathophysiology of progressive MS and the rationale for targeting BTK inhibitors. He reviews emerging clinical data supporting the use of BTK inhibitors and discusses how they may fit into the evolving treatment landscape. In this context, Prof. Montalban also considers current guideline-recommended therapies for progressive MS and highlights key areas of remaining unmet treatment need. The expert Prof. Xavier Montalban, Centre d'Esclerosi Múltiple de Catalunya (Cemcat) and Vall d'Hebron University Hospital, Barcelona, Spain This touchPODCAST is for HCPs outside of the UK only. This activity is provided by an independent medical education grant from Sanofi. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchneurology.com/…
touchPANEL DISCUSSION for touchNEUROLOGY Listen to two expert neurologists and a neurology nurse as they explore the role of neonatal Fc receptor (FcRn) inhibitors in improving the burden of disease in patients with generalized myasthenia gravis. The faculty will consider how the burden of disease and treatment in patients with generalized myasthenia gravis can be used to inform treatment decisions, the latest clinical data for FcRn inhibitors and the best practice strategies for using FcRn inhibitors in clinical practice. The experts Prof. Michael Nicolle – Western University and London Health Sciences Centre, London, ON, Canada Dr Karissa Gable – Duke University, Durham, NC, USA Ms Missy Pittman – Duke University, Durham, NC, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Argenx and UCB, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchneurologyime.org/reducing-burden-of-disease-in-gmg-exploring-the-role-of-fcrn-inhibitors/…
t
touchPODCAST

Listen to key experts from a multidisciplinary team review and discuss why and how to implement continuous glucose monitoring in T2D. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa Nurse specialist: Ms. Lori Berard Patient advocate: Mr. Ostap Soroka This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/…
Listen to key experts from a multidisciplinary team review and discuss evolving options for insulin therapy. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/…
Listen to key experts from a multidisciplinary team review and discuss clinical inertia in T2D. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa Patient advocate: Mr. Ostap Soroka This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/…
touchSYMPOSIUM for touchONCOLOGY Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France. Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC. Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/…
touchSYMPOSIUM for touchRESPIRATORY Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France. Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC. Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/…
t
touchPODCAST

1 Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchNEUROLOGY 33:43
touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes. The experts Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA Dr Christina Lampe, University of Giessen, Giessen, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Chiesi USA, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit: touchneurologyime.org/…
t
touchPODCAST

1 Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchENDOCRINOLOGY 33:45
touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes. The experts Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA Dr Christina Lampe, University of Giessen, Giessen, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Chiesi USA, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit: touchendocrinologyime.org/…
t
touchPODCAST

1 The evolving standard of care for advanced/recurrent endometrial cancer: A practice-focused discussion of immunotherapy 38:58
touchIN CONVERSATION for touchONCOLOGY Listen to two expert gynaecologic oncology specialists discuss the evolving role of immunotherapy in the treatment of advanced/recurrent endometrial cancer. They explore how immune checkpoint inhibitors are reshaping standards of care across lines of therapy, highlight key practical considerations for optimizing patient selection and management, and examine emerging data that may influence future treatment paradigms. The experts Dr Alexandra Leary, Gustave Roussy Cancer Center, Villejuif, France Dr Juan Francisco Grau, Gustave Roussy Cancer Center, Villejuif, France This touchPODCAST is for HCPs outside of the USA and UK only. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/…
touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three experts as they explore the burden of myelofibrosis and anaemia and/or thrombocytopenia, discuss targeted treatment strategies and how to maximize benefits for patients. The experts Prof. Haifa Kathrin Al-Ali – University Hospital of Halle, Halle (Saale), Germany Prof. Jean-Jacques Kiladjian – Université Paris Cité and Saint-Louis Hospital, Paris, France Prof. Alessandro Vannucchi – University of Florence, Florence, Italy This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchhaematologyime.org/…
t
touchPODCAST

1 Video 3: MDT perspectives on identifying and managing key ADC treatment toxicities in patients with metastatic breast cancer 11:54
Listen to key experts from a multidisciplinary team consider the strategies to avoid, mitigate, identify and effectively manage side effects associated with ADCs in patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA Clinical oncology pharmacy specialist: Dr Scott Edwards, Dr. H. Bliss Murphy Cancer Center, St. John’s, Newfoundland, Canada This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com…
t
touchPODCAST

1 Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer 13:03
Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC treatment to patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA Patient advocate: Mrs Lesley Turner, Independent Cancer Patients’ Voice, UK This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com…
t
touchPODCAST

1 Video 1: MDT perspectives on the safety profiles of current and emerging ADCs in metastatic breast cancer 11:59
Listen to key experts from a multidisciplinary team review and discuss the safety profiles of current and emerging ADCs in patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com…
t
touchPODCAST

1 Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease 19:12
touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to retina specialist Prof. Peter Kaiser answer a series of questions on the current clinical landscape for neovascular age-related macular degeneration and diabetic macular oedema, share his perspective on how newly available treatments are influencing the existing standard of care and provide guidance on how new therapies can be effectively integrated into clinical practice. The expert Prof. Peter Kaiser, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA This touchPODCAST is for HCPs outside of the USA and UK only. This activity is funded by an independent medical education grant from Bayer Consumer Care AG. The activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchophthalmologyime.org/adopting-emerging-therapies-for-retinal-diseases…
t
touchPODCAST

1 Expanding horizons for patients with Pompe disease: Using data to guide clinical practice 1:06:26
1:06:26
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked1:06:26
touchCONGRESS for touchCARDIO Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mozaffar, Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below Clinical themes Clinical and real-world data on long-term outcomes in Pompe disease Outcomes and impact of treatment switching in Pompe disease Latest clinical data on current and emerging therapies in Pompe disease The internationally renowned Pompe disease expert faculty Prof. Tahseen Mozaffar, Irvine, CA, USA Dr Jennifer L Cohen, Durham, NC, USA Prof. Benedikt Schoser, Munich, German This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:…
t
touchPODCAST

1 Expanding horizons for patients with Pompe disease: Using data to guide clinical practice 1:06:27
1:06:27
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked1:06:27
touchCONGRESS for touchENDOCRINOLOGY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mozaffar, Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below Clinical themes Clinical and real-world data on long-term outcomes in Pompe disease Outcomes and impact of treatment switching in Pompe disease Latest clinical data on current and emerging therapies in Pompe disease The internationally renowned Pompe disease expert faculty Prof. Tahseen Mozaffar, Irvine, CA, USA Dr Jennifer L Cohen, Durham, NC, USA Prof. Benedikt Schoser, Munich, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:…
t
touchPODCAST

1 Expanding horizons for patients with Pompe disease: Using data to guide clinical practice 1:06:26
1:06:26
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked1:06:26
touchCONGRESS for touchNEUROLOGY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mozaffar, Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below Clinical themes Clinical and real-world data on long-term outcomes in Pompe disease Outcomes and impact of treatment switching in Pompe disease Latest clinical data on current and emerging therapies in Pompe disease The internationally renowned Pompe disease expert faculty Prof. Tahseen Mozaffar, Irvine, CA, USA Dr Jennifer L Cohen, Durham, NC, USA Prof. Benedikt Schoser, Munich, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:…
t
touchPODCAST

1 Expanding horizons for patients with Pompe disease Using data to guide clinical practice 1:06:27
1:06:27
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked1:06:27
touchCONGRESS for touchRESPIRATORY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mozaffar, Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below Clinical themes Clinical and real-world data on long-term outcomes in Pompe disease Outcomes and impact of treatment switching in Pompe disease Latest clinical data on current and emerging therapies in Pompe disease The internationally renowned Pompe disease expert faculty Prof. Tahseen Mozaffar, Irvine, CA, USA Dr Jennifer L Cohen, Durham, NC, USA Prof. Benedikt Schoser, Munich, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:…
Willkommen auf Player FM!
Player FM scannt gerade das Web nach Podcasts mit hoher Qualität, die du genießen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos geräteübergreifend zu synchronisieren.